| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T318 |
0-191 |
Sentence |
denotes |
Most of the information regarding Gl adverse events come from indirect evidence from medications that are FDA-approved for other indications, such as the chloroquines and lopinavir/ritonavir. |
| T319 |
192-387 |
Sentence |
denotes |
In particular, Gl adverse events are poorly understood for both favipiravir and remdesivir, including the frequency and severity of aminotransferase elevations and incidence of Gl manifestations. |
| T320 |
388-516 |
Sentence |
denotes |
As ongoing clinical trials are completed regarding efficacy of therapy, additional data regarding Gl adverse events will emerge. |
